Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
US-10456364-B2 · Oct 29, 2019 · US
This page is not indexed by search engines while we improve data quality.
Brahms Gmbh patents in 2019
Brahms Gmbh was listed as an assignee on 7 patent publications in 2019.
| Metric | Value |
|---|---|
| Company | Brahms Gmbh |
| Year | 2019 |
| Patents | 7 |
Patents
Representative publications for Brahms Gmbh in 2019.
Procalcitonin for the prognosis of adverse events
US-2019227081-A1 · Jul 25, 2019 · US
Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
US-2019224135-A1 · Jul 25, 2019 · US
Histones and/or proadm as markers indicating organ dysfunction
US-2019178897-A1 · Jun 13, 2019 · US
Histones and/or proadm as markers indicating an adverse event
US-2019178894-A1 · Jun 13, 2019 · US
Top CPC classifications
Most common classification codes for Brahms Gmbh in 2019.
| CPC | Patents |
|---|---|
| G01N33/74 | 6 |
| G01N33/6893 | 5 |
| G01N2333/585 | 4 |
| G01N33/68 | 3 |
| A61K31/00 | 2 |
Related pages
Navigate to parent entity pages.